The role of mRNA secondary structures in programmed termination codon readthrough
mRNA二级结构在程序性终止密码子通读中的作用
基本信息
- 批准号:BB/G020272/1
- 负责人:
- 金额:$ 42.69万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2009
- 资助国家:英国
- 起止时间:2009 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Whilst a cell's proteins are encoded in DNA (the genetic material), they are synthesised by an organelle called the ribosome through an intermediate molecule, messenger RNA (mRNA), that is transcribed from DNA. The appropriate end of the mRNA is fed into the ribosome which moves along until a triplet start signal in the mRNA is recognised. At this point, amino acid biosynthesis starts and as each subsequent triplet nucleotide 'code' is decoded, one amino acid is added to a growing amino acid chain. The ribosome continues along the mRNA until it recognises a triplet stop signal, at which point translation normally terminates and the completed amino acid polymer, the protein, is released. However in some instances, the stop signal is not recognised correctly (it is said to be 'leaky'), and instead, an amino acid is added and protein synthesis continues. This is called stop codon readthrough and is the subject of our investigation. Stop codon readthrough is used by cells and viruses to make, at a certain frequency, an elongated version of a protein, which has altered properties. We are interested in determining how the structure of the mRNA in the vicinity of the 'leaky' stop codon can cause the ribosome to fail to recognise the stop efficiently. At present, we know little about the RNA structures that promote readthrough. In this project, we will examine the structures from three different readthrough signals and look for common features to give us clues as to how the ribosome is being mislead. A deeper knowledge of this process will provide insights into the biology of gene expression and our knowledge of ribosome function.
虽然细胞的蛋白质是在 DNA(遗传物质)中编码的,但它们是由称为核糖体的细胞器通过从 DNA 转录的中间分子信使 RNA (mRNA) 合成的。 mRNA 的适当末端被送入核糖体,核糖体会一直移动,直到识别出 mRNA 中的三联体起始信号。此时,氨基酸生物合成开始,并且随着每个后续三联体核苷酸“代码”被解码,一个氨基酸被添加到不断增长的氨基酸链中。核糖体继续沿着 mRNA 前进,直到识别出三联体停止信号,此时翻译通常终止,并释放完整的氨基酸聚合物(蛋白质)。然而,在某些情况下,停止信号未被正确识别(据说是“泄漏”),而是添加氨基酸并继续蛋白质合成。这称为终止密码子通读,是我们调查的主题。细胞和病毒使用终止密码子通读以一定的频率制造蛋白质的延长版本,该蛋白质已改变了特性。我们感兴趣的是确定“泄漏”终止密码子附近的 mRNA 结构如何导致核糖体无法有效识别终止密码子。目前,我们对促进通读的 RNA 结构知之甚少。在这个项目中,我们将检查三个不同通读信号的结构,并寻找共同特征,为我们提供有关核糖体如何被误导的线索。对这一过程的更深入的了解将有助于深入了解基因表达的生物学和我们对核糖体功能的了解。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Non-canonical translation in RNA viruses.
- DOI:10.1099/vir.0.042499-0
- 发表时间:2012-07
- 期刊:
- 影响因子:0
- 作者:Firth AE;Brierley I
- 通讯作者:Brierley I
Ribosome profiling of the retrovirus murine leukemia virus.
- DOI:10.1186/s12977-018-0394-5
- 发表时间:2018-01-22
- 期刊:
- 影响因子:3.3
- 作者:Irigoyen N;Dinan AM;Brierley I;Firth AE
- 通讯作者:Firth AE
Modulation of stop codon read-through efficiency and its effect on the replication of murine leukemia virus.
- DOI:10.1128/jvi.00898-14
- 发表时间:2014-09
- 期刊:
- 影响因子:5.4
- 作者:Csibra E;Brierley I;Irigoyen N
- 通讯作者:Irigoyen N
Characterization of the stop codon readthrough signal of Colorado tick fever virus segment 9 RNA.
- DOI:10.1261/rna.030338.111
- 发表时间:2012-02
- 期刊:
- 影响因子:4.5
- 作者:S. Napthine;Christina Yek;Michael L. Powell;T. Brown;I. Brierley
- 通讯作者:S. Napthine;Christina Yek;Michael L. Powell;T. Brown;I. Brierley
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ian Brierley其他文献
Ian Brierley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ian Brierley', 18)}}的其他基金
Probing the mechanism of action of Shiftless, a host restriction factor targeting programmed ribosomal frameshifting.
探究 Shiftless 的作用机制,这是一种针对程序化核糖体移码的宿主限制因子。
- 批准号:
BB/V000306/1 - 财政年份:2021
- 资助金额:
$ 42.69万 - 项目类别:
Research Grant
Probing the translational dynamics of influenza virus infection.
探讨流感病毒感染的转化动力学。
- 批准号:
MR/M011747/1 - 财政年份:2015
- 资助金额:
$ 42.69万 - 项目类别:
Research Grant
The role of viral and cellular proteins in programmed -2 ribosomal frameshifting
病毒和细胞蛋白在程序性-2核糖体移码中的作用
- 批准号:
BB/L000334/1 - 财政年份:2013
- 资助金额:
$ 42.69万 - 项目类别:
Research Grant
Structural and functional analysis of ribosome initiation and ribosomal frameshifting.
核糖体起始和核糖体移码的结构和功能分析。
- 批准号:
BB/G008205/1 - 财政年份:2009
- 资助金额:
$ 42.69万 - 项目类别:
Research Grant
Cryo-EM analysis of ribosomal frameshifting
核糖体移码的冷冻电镜分析
- 批准号:
BB/D009499/1 - 财政年份:2006
- 资助金额:
$ 42.69万 - 项目类别:
Research Grant
Molecular analysis of a novel translation 'termination-reinitiation' signal
新型翻译“终止-重新启动”信号的分子分析
- 批准号:
BB/C007034/1 - 财政年份:2006
- 资助金额:
$ 42.69万 - 项目类别:
Research Grant
相似国自然基金
肠道菌群及其代谢产物通过mRNA m6A修饰调控猪肉品质的机制研究
- 批准号:32330098
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
保守的mRNA核质转运蛋白DDX-19调控生殖颗粒稳态的分子机制研究
- 批准号:32370729
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
心源性猝死预警新机制-棕榈酰化转移酶Zdhhc5 pre-mRNA可变剪接调控Cav1.2相分离
- 批准号:82370328
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
脂质多聚复合物mRNA纳米疫苗的构筑及抗肿瘤治疗研究
- 批准号:52373161
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ALYREF靶向PD-L1mRNA的m5C甲基化修饰介导NSCLC免疫逃逸分子机制研究
- 批准号:82373226
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Mechanism of Eccentric Cardiomyocyte Hypertrophy Secondary to Mitral Regurgitation
二尖瓣反流继发偏心心肌细胞肥大的机制
- 批准号:
10565204 - 财政年份:2023
- 资助金额:
$ 42.69万 - 项目类别:
Mechanisms of protective memory CD8 T-cell induction by mRNA-LNP vaccines
mRNA-LNP 疫苗诱导保护性记忆 CD8 T 细胞的机制
- 批准号:
10753981 - 财政年份:2023
- 资助金额:
$ 42.69万 - 项目类别:
Hypoxia-Inducible Factors and Neutrophil Heterogeneity in Myeloproliferative Neoplasm-Associated Venous Thrombosis
骨髓增生性肿瘤相关静脉血栓形成中的缺氧诱导因素和中性粒细胞异质性
- 批准号:
10740120 - 财政年份:2023
- 资助金额:
$ 42.69万 - 项目类别:
IL-17A mRNA-targeted oligonucleotide therapeutics in Idiopathic Pulmonary Fibrosis (IPF)
IL-17A mRNA 靶向寡核苷酸治疗特发性肺纤维化 (IPF)
- 批准号:
10761365 - 财政年份:2023
- 资助金额:
$ 42.69万 - 项目类别:
Mechanisms and targeting of aberrant Gas activation in myeloid neoplasms
骨髓肿瘤中异常气体激活的机制和靶向
- 批准号:
10659809 - 财政年份:2023
- 资助金额:
$ 42.69万 - 项目类别: